Alstrom Syndrome International

Income Statement
Fiscal Year Start:
Jan 1
Revenues in 2024
$256,802
Contributions
59%
Government Grants
39%
Fundraising Events
2%
Program Services
0%
Membership Dues
0%
Investments
0%
Other
0%
Expenses in 2024
$174,244
Fees to Service Providers
44%
Other
37%
Offices, Occupancy & IT
13%
Advertising & Promotion
6%
Depreciation
<1%
Grants
0%
Benefits to Members
0%
Salaries & Benefits
0%
Interest
0%
Revenues
2023
2024
Change
Contributions
$253,979
$150,885
-41%
Government Grants
$0
$100,000
-
Fundraising Events
$0
$5,917
-
Program Services
$0
$0
-
Membership Dues
$0
$0
-
Investments
$18
$0
-100%
Other
$0
$0
-
Total Revenues
$253,997
$256,802
+1%
Expenses
2023
2024
Change
Grants
$0
$0
-
Benefits to Members
$0
$0
-
Salaries & Benefits
$0
$0
-
Fees to Service Providers
$61,793
$76,220
+23%
Advertising & Promotion
$0
$10,087
-
Offices, Occupancy & IT
$17,778
$23,250
+31%
Interest
$0
$0
-
Depreciation
$44
$11
-75%
Other
$155,046
$64,676
-58%
Total Expenses
$234,661
$174,244
-26%
Net income
2023
2024
Change
Net income
+$19,336
+$82,558
+327%
Functional Expenses
Summary
2023
2024
Change
Program
$173,983
$86,804
-50%
Admin
$60,678
$81,050
+34%
Fundraising
$0
$6,390
-
Total Expenses
$234,661
$174,244
-26%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)